Vascular neurosurgery: Aneurysms, arteriovenous malformations, subarachnoid hemorrhage, and intracranial hemorrhage

Current Opinion in Neurology

Volumn 9, Issue 1, 1996, Pages 57-61

  Guterman, L R ^a   Jenkins, J A ^b   Borchers, D J ^b   Rodriguez, R ^b   Hopkins, L N ^b  

^a MILLARD FILLMORE HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; PAPAVERINE; TISSUE PLASMINOGEN ACTIVATOR;

ANEURYSM; ARTERIOVENOUS MALFORMATION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CEREBROVASCULAR SURGERY; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; RISK; SHORT SURVEY; SUBARACHNOID HEMORRHAGE; VASOSPASM;

EID: 0029927817     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199602000-00012     Document Type: Short Survey

References (34)

1. Graves VB, Strother CM, Duff TA, Perl J: Early treatment of ruptured aneurysms with Guglielmi detachable coils: effect on subsequent bleeding. Neurosurgery 1995, 37:640-648.
2. Zubillaga AF, Guglielmi G, Viñuela F, Duckwiler GR: Endovascular occlusion of intracranial aneurysms with electrically detachable coils: correlation of aneurysm neck size and treatment resuls. AJNR 1994, 15:815-820. This paper describes the aneurysm morphology most amenable to coil treatment. Statistics are provided on treatment failures and successes relative to aneurysm anatomy.
3. Larson JJ, Tew JM, Tomsick TA, van Loveren HR: Treatment of aneurysms of the internal carotid artery by intravascular balloon occlusion: long-term follow-up of 58 patients. Neurosurgery 1995, 36:23-30. A report of a long-term follow up in a cohort of patients treated by balloon occlusion. The morbidity and mortality of the procedures are reported. Delayed complications are considered.
4. Marks MP, Chee H, Liddell RP, Steinberg GK, Panahian N, Lane B: A mechanically detachable coil for the treatment of aneurysms and occlusion of blood vessels. AJNR 1994, 15:821-827.
5. Kinugasa K, Mandai S, Tsuchida S, Sugiu K, Kamata I, Tokunaga K, Ohmoto T, Taguchi K: Cellulose acetate polymer thrombosis for the emergency treatment of aneurysms : angiographic findings, clinical experience, and histopathological study. Neurosurgery 1994, 34:694-701.
6. Kinugasa K, Mandai S, Kamata I, Tokunaga K, Sugiu K, Handa A, Nakashima H, Ohmoto T: Prophylactic thrombosis to prevent new bleeding and to delay aneurysm surgery. Neurosurgery 1995, 36:661-667.
7. Kinugasa K, Kamata I, Hirotsune N, Tokunaga K, Sugiu K, Handa A, Nakashima H, Ohmoto T, Mandai S, Matsumoto Y: Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm. J Neurosurg 1995, 83:34-41. The authors describe the use of CAP as a treatment to prevent early rebleed and facilitate the use of intracisternal thrombolysis.
8. Mercier P, Alhayek G, Rizk T, Fournier D, Menei P, Guy G: Are the calcium antagonists really useful in cerebral aneurysmal surgery? A retrospective study. Neurosurgery 1994, 34:30-37. The authors question the benefit of calcium anatogists for patients with SAH.
9. Juvela S. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 1995, 82:945-952.
10. Bontozoglou N, Spanos H, Lasjaunias P, Zarifis: Three-dimensional display of the orifice of intracranial aneurysms: a new potential application for magnetic resonance angiography. Neuroradiology 1994, 36:346-349. Stunning pictures of the orifices of aneurysms.
11. Lawton MT, Hamilton MG, Spetzler RF: Multimodality treatment of deep arteriovenous malformations: thalamus, basal ganglia, and brain stem. Neurosurgery 1995, 37:29-36.
12. Hurst RW, Berenstein A, Kupersmith MJ, Madrid M, Flamm ES: Deep central arteriovenous malformations of the brain: the role of endovascular treatment. J Neurosurg 1995, 82:190-195.
13. Friedman WA, Bova FJ, Mendenhall WM: Linear accelerator radiosurgery for arteriovenous malformations: the relationship of size to outcome. J Neurosurg 1995, 82:180-189.
14. Wallace RC, Flom RA, Khayata MH, Dean BL, McKenzie J, Rand JC, Obuchowski NA, Zepp RC, Zabramski JM, Spetzler RF. The safety and effectiveness of brain arteriovenous malformation embolization using acrylic and particles: the experiences of a single institution. Neurosurgery 1995, 37:606-618
15. Young WL, Pile-Spellman J, Prohivnik I, Kader A, Stein BM: Evidence for adaptive autoregulatory displacement in hypotensive cortical territories adjacent to arteriovenous malformations. Neurosurgery 1994, 34: 601-611. An excellent clinical experiment that attempted to define the autoregulatory status of blood vessels adjacent to cerebral AVMs and their ability to regulate CBF.
16. Kader A, Young WL, Pile-Spellman J, Mast H, Sciacca RR, Mohr JP, Stein BM: The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1994, 34:801-808. A large series of patients in whom multiple parameters associated with AVMs were carefully studied and results correlated to clinical findings.
17. Massaro AR, Young WL, Kader A, Ostapkovich N, Tatemichi TK, Stein BM, Mohr JP: Characterization of arteriovenous malformation feeding vessels by carbon dioxide reactivity. AJNR 1994, 15:55-61.
18. Vardiman AB, Kopitnik TA, Purdy PD, Batjer HH, Samson DS: Treatment of traumatic arterial vasospasm with intraarterial papaverinee infusion. AJNR 1995, 16:319-321.
19. Hendrix LE, Dion JE, Jensen ME, Phillips CD, Newman SA: Papaverine-induced mydriasis. AJNR 1994, 15:716-718.
20. Barr JD, Mathis JM, Horton JA: Transient severe brain stem depression during intraarterial papaverinee infusion for cerebral vasospasm. AJNR 1994, 15:719-723. The authors relate the potentially devastating effects of intraarterial papaverine injections.
21. Mathis JM, DeNardo A, Jensen ME, Scott J, Dion JE: Transient neurologic events associated with intraarterial papaverinee infusion for subarachnoid hemorrhage-induced vasospasm. AJNR 1994, 15:1671-1674.
22. Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM: Intraarterial papaverinee infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR 1995, 16:27-38. The outcome data and complication rates of a series of patients treated with intraarterial papaverine for vasospasm.
23. Usui M, Saito N, Hoya K, Todo T: Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cistemal drainage alone. Neurosurgery 1994, 34:235-245.
24. Sasaki T, Ohta T, Kikuchi H, Takakura K, Usui M, Ohnishi H, Kondo A, Tanabe H, Nakamura J, Yamada K, et al. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1994, 35:597-605. The first phase II trial that indicated that thrombolytic therapy may help prevent symptomatic vasospasm.
25. Witt JP, Yonas H, Jungreis C: Cerebral blood flow response pattern during balloon test occlusion of the internal carotid artery. AJNR 15:847-857. A complex report that attempts to sort out xenon-computerized tomography CBF studies in patients with temporary balloon occlusion of the ICA. The authors indicate which patients need extracranial-intracranial bypass before artery sacrifice.
26. Linskey ME, Jungreis CA, Yonas H, Hirsch WL, Sekhar LN, Horton JA, Janosky JE: Stroke risk after abrupt internal carotid artery sacrifice: accuracy of preoperative assessment with balloon test occlusion and stable xenon-enhanced CT. AJNR 1994, 15:829-843.
27. Standard SC, Ahuja A, Guterman LR, Chavis TD, Gibbons KJ, Barth AP, Hopkins LN: Balloon test occlusion of the internal carotid artery with hypotensive challenge. AJNR 1995, 16:1453-1458. An excellent method for determining which patients need extracranial-intracranial bypass before artery sacrifice without using computerized tomography CBF measurements.
28. Mathis JM, Barr JD, Jungreis CA, Yonas H, Sekhar LN, Vincent D, Pentheny SL, Horton JA: Temporary balloon test occlusion of the internal carotid artery: experience in 500 cases. AJNR 1995, 16:749-754.
29. Russell EJ, Goldberg K, Oskin J, Darling C, Melen O: Ocular ischemic syndrome during carotid balloon occlusion testing. AJNR 1994, 15:258-262.
30. Timperman PE, Tomsick TA, Tew JM, van Loveren HR: Aneurysm formation after carotid occlusion. AJNR 1995, 16:329-331.
31. Hurst RW, Goldberg HI: Transient monocular blindness in carotid occlusion testing. AJNR 1994, 15:255-257.
32. Lewis AI, Tomsick TA, Rew JM: Management of 100 consecutive direct carotid-cavernous fistulas: results of treatment with detachable balloons. Neurosurgery 1995, 36:239-245. The authors describe a large patient series with carotid-cavernous fistulas with long-term follow up as well as morbidity and mortality data.
33. Srinivasan J, Mayberg MR, Weiss DG, Eskridge J: Duplex accuracy compared with angiography in the Veterans Affairs Cooperative Studies Trial for Symptomatic Carotid Stenosis. Neurosurgery 1995, 36:648-655.
34. Lustgarten JH, Solomon RA, Quest DO, Khanjdi AG, Mohr JP: Carotid endarterectomy after noninvasive evaluation by duplex ultra-sonography and magnetic resonance angiography. Neurosurgery 1994, 34:612-619.